rs2523505

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000458640.5(DDX39B):​c.-278G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.063 in 666,924 control chromosomes in the GnomAD database, including 1,647 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.075 ( 449 hom., cov: 33)
Exomes 𝑓: 0.060 ( 1198 hom. )

Consequence

DDX39B
ENST00000458640.5 5_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.725

Publications

13 publications found
Variant links:
Genes affected
DDX39B (HGNC:13917): (DExD-box helicase 39B) This gene encodes a member of the DEAD box family of RNA-dependent ATPases that mediate ATP hydrolysis during pre-mRNA splicing. The encoded protein is an essential splicing factor required for association of U2 small nuclear ribonucleoprotein with pre-mRNA, and it also plays an important role in mRNA export from the nucleus to the cytoplasm. This gene belongs to a cluster of genes localized in the vicinity of the genes encoding tumor necrosis factor alpha and tumor necrosis factor beta. These genes are all within the human major histocompatibility complex class III region. Mutations in this gene may be associated with rheumatoid arthritis. Alternative splicing results in multiple transcript variants. Related pseudogenes have been identified on both chromosomes 6 and 11. Read-through transcription also occurs between this gene and the upstream ATP6V1G2 (ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2) gene. [provided by RefSeq, Feb 2011]
ATP6V1G2-DDX39B (HGNC:41999): (ATP6V1G2-DDX39B readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring ATP6V1G2 (ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2) and DDX39B (DEAD box polypeptide 39B) genes located in the major histocompatibility complex class III region of chromosome 6. The read-through transcript and is a candidate for nonsense-mediated mRNA decay (NMD), and is thus unlikely to produce a protein product. [provided by RefSeq, Feb 2011]
DDX39B-AS1 (HGNC:39771): (DDX39B antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0894 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DDX39BNM_004640.7 linkc.-408G>C upstream_gene_variant ENST00000396172.6 NP_004631.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP6V1G2-DDX39BENST00000376185.5 linkn.184-77G>C intron_variant Intron 2 of 12 2 ENSP00000365356.1
DDX39BENST00000396172.6 linkc.-408G>C upstream_gene_variant 1 NM_004640.7 ENSP00000379475.1

Frequencies

GnomAD3 genomes
AF:
0.0753
AC:
10819
AN:
143718
Hom.:
451
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0921
Gnomad AMI
AF:
0.0340
Gnomad AMR
AF:
0.0806
Gnomad ASJ
AF:
0.0672
Gnomad EAS
AF:
0.0228
Gnomad SAS
AF:
0.0170
Gnomad FIN
AF:
0.0365
Gnomad MID
AF:
0.0516
Gnomad NFE
AF:
0.0788
Gnomad OTH
AF:
0.0813
GnomAD4 exome
AF:
0.0597
AC:
31212
AN:
523086
Hom.:
1198
Cov.:
0
AF XY:
0.0569
AC XY:
15905
AN XY:
279288
show subpopulations
African (AFR)
AF:
0.0900
AC:
1356
AN:
15064
American (AMR)
AF:
0.0656
AC:
2171
AN:
33086
Ashkenazi Jewish (ASJ)
AF:
0.0617
AC:
1187
AN:
19234
East Asian (EAS)
AF:
0.0101
AC:
316
AN:
31392
South Asian (SAS)
AF:
0.0204
AC:
1248
AN:
61034
European-Finnish (FIN)
AF:
0.0344
AC:
1138
AN:
33100
Middle Eastern (MID)
AF:
0.0393
AC:
156
AN:
3974
European-Non Finnish (NFE)
AF:
0.0736
AC:
21852
AN:
297006
Other (OTH)
AF:
0.0612
AC:
1788
AN:
29196
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1515
3029
4544
6058
7573
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
120
240
360
480
600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0752
AC:
10812
AN:
143838
Hom.:
449
Cov.:
33
AF XY:
0.0721
AC XY:
5081
AN XY:
70474
show subpopulations
African (AFR)
AF:
0.0918
AC:
3765
AN:
41000
American (AMR)
AF:
0.0804
AC:
1158
AN:
14400
Ashkenazi Jewish (ASJ)
AF:
0.0672
AC:
225
AN:
3350
East Asian (EAS)
AF:
0.0229
AC:
118
AN:
5162
South Asian (SAS)
AF:
0.0168
AC:
79
AN:
4706
European-Finnish (FIN)
AF:
0.0365
AC:
357
AN:
9790
Middle Eastern (MID)
AF:
0.0486
AC:
14
AN:
288
European-Non Finnish (NFE)
AF:
0.0788
AC:
4910
AN:
62328
Other (OTH)
AF:
0.0794
AC:
158
AN:
1990
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
534
1068
1602
2136
2670
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0724
Hom.:
57
Bravo
AF:
0.0789
Asia WGS
AF:
0.0210
AC:
73
AN:
3460

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
2.7
DANN
Benign
0.39
PhyloP100
-0.72
PromoterAI
-0.0014
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2523505; hg19: chr6-31510002; API